Angiotensinogen (AGT) (NM_000029) Human Recombinant Protein

CAT#: TP721058

Purified recombinant protein of Human angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (AGT)

Specifications

Product Data

• Species: Human
• Expression Host: HEK293
• Expression cDNA Clone or AA Sequence:
  Protein Sequence

  Asp34-Ala485
• Tag: C-His
• Predicted MW: 51.7 kDa
• Purity: >95% as determined by SDS-PAGE and Coomassie blue staining
• Buffer: Supplied as a 0.2 um filtered solution of 20mM PB, 150mM NaCl, pH 7.4.
• Endotoxin: Endotoxin level is < 0.1 ng/µg of protein (< 1 EU/µg)
• Storage: Store at < -20°C, stable for 6 months after receipt. Please minimize freeze-thaw cycles.
• Stability: Stable for at least 3 months from date of receipt under proper storage and handling conditions.

Reference Data

• RefSeq: NP_000020
• Locus ID: 183
• UniProt ID: P01019, B0ZBE2, B2R5S1
• Cytogenetics: 1q42.2
• Refseq Size: 2587
• Refseq ORF: 1455
• Synonyms: ANHU; hFLT1; SERPINA8
• Summary: The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure, body fluid and electrolyte homeostasis, and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. [provided by RefSeq, Nov 2019]
• Protein Families: Druggable Genome, Secreted Protein
• Protein Pathways: Renin-angiotensin system